From simply delicious water to healthy water. HOME SITE MAP Japanese
Nihon Trim Co.,Ltd. People,Life,Water Company Guide Research and Development Investor Relations
Japanese
Return to Research and Development
HOME >> Research and Development >> Hemodialysis International Abstract of a paper published in June 2007
Related Infomation
Abstracts of Scientific Papers
PLOS ONE
(September 2017)
PLOS ONE
(February 2017)
Renal Replacement Therapy
(June 2016)
Environmental Control
In Biology
(July 2014)
Medical Gas Research
(December 2013)
Hemodial International
(November 2013)
PLoS ONE
(July 2012)
Cytotechnology
(June 2012)
Trends in Food Science and Technology
(November 2011)
BMC Proceedings
(November 2011)
BMC Proceedings
(November 2011)
Bioscience,
Biotechnology,
and Biochemistry
(July 2011)
Nephrology Dialysis Transplantation
(December 2010)
Cytotechnology
(November 2010)
Bioscience,
Biotechnology,
and Biochemistry
(October 2010)
Nephrology Dialysis Transplantation
(April 2010)
Nephrology Dialysis Transplantation
(February 2010)
Free Radical Research
(January 2010)
Nephron Clinical Practice
(April 2009)
Langmuir
(June 2008)
Biological & Pharmaceutical Bulletin
(January 2008)
Hemodialysis International
(June 2007)
Kidney International
(July 2006)
Cytotechnology
(January 2005)
Kidney International
Vol.64 (July 2003)
Cytotechnology
(June 2003)
BBRC
(BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS)
(May 1997)
List of Papers and Conference Presentations on Electrolyzed Reduced Water
What is electrolyzed reduced water?
Hemodialysis International 2007; 11:322-327 Abstract of a paper published in June 2007
Less-oxidative hemodialysis solution rendered by cathode-side application of electrolyzed water
Electrolyzed water (EW) generated on the cathode side reportedly displays anti-oxidative properties, and application of EW to hemodialysis (HD) systems supposedly suppresses oxidative markers in patients on HD. However, most of the chemical properties and biological effects of such solutions remain unclear. This study aimed to examine those issues to clarify the scientific background for the clinical use of EW solution. Reverse osmosis water comprising EW from the cathode side (e-RO) was prepared and used to process a test HD solution (e-HD). Chemical and biological properties of these solutions were compared with controls. Redox properties were examined by chemiluminescence (CL) of the luminol-H2O2 system. Biological effects of e-RO on human polymorphonuclear leukocytes (PMNs) were tested with respect to the cellular protection against methylglyoxal, and with respect to the preservation of cellular function as to radical generation. Control HD solution presented the highest CL, followed by e-HD, control RO, suggesting a lower oxidative capacity for EW-based solutions. Increased levels of dissolved hydrogen were characteristic of e-RO and e-HD. Application of e-RO tended to be associated with less injury of PMNs by methylglyoxal, and with significantly higher levels of radical generation compared with the control. Compared with control HD, e-RO-based HD solution displays less-oxidative capacity in chemical terms, and may at least partly facilitate preservation of PMN viability. These results appear to offer a scientific basis for supporting the clinical challenge of applying this technology to HD treatment.
Page Top
Nihon Trim Co.,Ltd.
Headquarters: 22nd Floor, Herbis Ent Office Tower, 2-2-22 Umeda, kita-ku, Osaka, 530-0001
Tel: +81-6-6456-4600 e-mail:info@nihon-trim.co.jp
Personal Information Protection Policy
Copyright 2006 Nihon Trim Co.,Ltd. All rights reserved. Unauthorized reproduction of illustrations, photographs,or trademarks on this Web site is prohibited.